.avif)
22nd January, 2026
Why Secondary Sales Visibility Is the Real Control Lever in Indian Pharma
Primary sales show intent. Secondary sales show reality. True control begins when pharma leaders can see
.avif)
18th January, 2026
The Distributor Black Box: Why Most Pharma Companies Can’t See Their Own Business
Distributors hold the most critical data in pharma, yet most companies operate without it.
14th January, 2026
Activity vs Impact: Measuring What Your Field Force Actually Moves
The real question is whether field effort is converting into downstream offtake, not just activity metrics.
.avif)
12th January, 2026
Dashboards Don’t Drive Decisions - Intelligence Does
Winning pharma teams move beyond static charts to decision-ready insights that change outcomes.
8th January, 2026
What ‘Downstream Intelligence’ Really Means (And Why It’s the Next Competitive Moat)
It’s how leading pharma companies turn fragmented data into a sustainable competitive advantage.
.avif)
3rd January, 2026
How Pharma Leaders Can Move From Data-Rich to Insight-Driven
The shift from reports to insights is what separates reactive teams from high-control operators.
